Z2H-26069-36922
4 vaccinations
4 coded responses
43 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 480 / MI
- Registered
- 2021-04-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
GSZ-15081-92229
Child or adolescent in my care · Male · 2022-06-29
RFH-31561-34475
Child or adolescent in my care · Female · 2023-05-08
Timeline
-
2021-03-21
Dose 1 — Pfizer-BioNTech
-
2021-04-11
Dose 2 — Pfizer-BioNTech
-
2021-04-13
Registered in v-safe
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-25
-
2021-05-03
Survey response — day 21, dose 2MedDRA: Heavy menstrual bleeding — Feeling: Good · Be unable to do your normal daily activitiesFree text: Very heavy first periodMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-09
-
2021-05-16
Survey response — day 35, dose 2MedDRA: Office visit, Uterine polyp — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Uterine polyps · Healthcare visit (other): Dr visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-16
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-23
- 2021-07-11
- 2021-10-10
-
2021-10-15
Dose 3 — Pfizer-BioNTech
-
2021-10-15
Health check-in — day 0, dose 3Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-16
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-17
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-19
- 2021-10-20
-
2021-10-21
Health check-in — days 1–6 daily, dose 3Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-22
Health check-in — day 7, dose 3Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-29
Survey response — day 14, dose 3MedDRA: Ovulation delayed — Feeling: GoodFree text: Late ovulation by about 9 daysMedDRA releases: 2024-11 · check-in free text available
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2022-01-14
- 2022-04-15
- 2022-05-11
-
2022-09-22
Dose 4 — Pfizer-BioNTech
-
2022-09-22
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain · Fatigue or tiredness, Abdominal painAdult check-in
-
2022-09-23
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-09-24
Survey response — days 1–6 daily, dose 4MedDRA: Anxiety — Feeling: Poor · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: AnxietyMedDRA releases: 2024-11 · check-in free text available
-
2022-09-25
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-09-26
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-27
- 2022-09-28
- 2022-09-29
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-10-27
- 2022-11-03
- 2022-12-22
- 2023-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-21 | Pfizer-BioNTech | |
| 2 | 2021-04-11 | Pfizer-BioNTech | |
| 3 | 2021-10-15 | Pfizer-BioNTech | No |
| 4 | 2022-09-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-16 | Unsuccessful |
Free text
Release 8 — day 21, dose 2
Symptoms: Very heavy first period
Release 8 — day 35, dose 2
Release 10 — day 14, dose 3
Symptoms: Late ovulation by about 9 days
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Anxiety
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Ovulation delayed | · | · | ✓ |
| SD | Uterine polyp | ✓ | ✓ | ✓ |
| SRO | Anxiety | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release